Can-Fite Biopharma (CANF.TA) Q1 2026 Earnings

Mar 26Confirmed
Q4 2024
Q2 2025
Q3 2025
Q1 2026
-932.04
-621.36
-310.68
0

Details

Expected EPS
0
Actual EPS
-932.0364
Surprise EPS
-932.04
Surprise Percent
N/A

Description

⁨Can-Fite Biopharma⁩ (⁦CANF.TA⁩) has reported earnings of ⁦-932.0364⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts